Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
Ferreira, Ana Flavia F., Ulrich, Henning, Feng, Zhong-Ping, Sun, Hong-Shuo, Britto, Luiz Roberto
Published in Experimental neurology (01.07.2024)
Published in Experimental neurology (01.07.2024)
Get full text
Journal Article
The transient receptor potential melastatin 2: a new therapeutical target for Parkinson's disease?
Ferreira, Ana Flávia F, Britto, Luiz Roberto G
Published in Neural regeneration research (01.08.2023)
Published in Neural regeneration research (01.08.2023)
Get full text
Journal Article
Deletion of the Transient Receptor Potential Melastatin 2 Gene Mitigates the 6-Hydroxydopamine-Induced Parkinson's Disease-Like Pathology
Ferreira, Ana Flavia F, Ulrich, Henning, Mori, Yasuo, Feng, Zhong-Ping, Sun, Hong-Shuo, Britto, Luiz Roberto
Published in Molecular neurobiology (14.11.2024)
Published in Molecular neurobiology (14.11.2024)
Get full text
Journal Article